Clinical Trials Logo

Clinical Trial Summary

The main hypothesis of this study is that transcranial magnetic neuromodulation can correct the symptoms of hypersensitivity and bladder pain. The investigators assume that under the influence of transcranial magnetic stimulation, both the subjective state of patients assessed by standardized questionnaires and the objective parameters assessed by invasive and non-invasive urodynamic studies will be improved. In this study, two protocols for magnetic stimulation of the supplementary motor area (SMA) will be compared with each other and with placebo. The investigators expect to determine the dependence of the therapeutic effect on the applied stimulation protocol.


Clinical Trial Description

The aim of the study is to test the hypothesis that the use of the magnetic stimulation method SMA in patients with symptoms of bladder hypersensitivity and bladder pain will help to reduce the clinical and urodynamic signs of these pathological conditions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04721210
Study type Interventional
Source Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation
Contact Gleb Kovalev, MD
Phone +78126004712
Email kovalev2207@gmail.com
Status Recruiting
Phase N/A
Start date January 20, 2021
Completion date January 20, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04807569 - The Effectiveness of Peripheral Magnetic Stimulation in Men With Lower Urinary Tract Symptoms N/A